Prognostic impact of bone involvement in Hodgkin lymphoma
(96 — 100)
D. FELTL, J. MARKOVA, H. MOCIKOVA, K. DEDECKOVA, T. KOZAK
Prognosis of pediatric patients transplanted for Ph+ chronic myeloid
leukemia in the period from 1989 to 2006 in the Czech Republic
(101 — 106)
L. KROL, R. FORMANKOVA, P. KESLOVA, V. VAVRA, Z. ZEMANOVA, K. MICHALOVA, M. DOBROVOLNA, J. MORAVCOVA,
P. KOBYLKA, E. IVASKOVA, J. NAVRATILOVA, J. STARY, P. SEDLACEK
The influence of serum HER-2 levels and HER-2 codon 655 polymorphism
on breast cancer outcome
(113 — 121)
E. PAPADOPOULOU, G. TRIPSIANIS, K. ANAGNOSTOPOULOS, I. TENTES, S. KAKOLYRIS, G. GALAZIOS, E. SIVRIDIS, K. SIMOPOULOS, A. KORTSARIS
Neoadjuvant Therapy with Celecoxib to Women with Early Stage Breast Cancer
(122 — 126)
A. TFAYLI, J. YANG, K. KOJOURI1, C. KESSERWAN, M. JAFARI, H. OZER
Antitumor and biological effects of black pine (pinus nigra) pollen nuclease
(158 — 164)
P. LIPOVOVA, T. PODZIMEK, L. ORCTOVA, J. MATOUSEK, P. POUCKOVA, J. SOUCEK, J. MATOUSEK